Library
PubMed Central Open Access
research article
Professional
Open access

Biallelic variants in IBA57 with multiple mitochondrial dysfunction syndrome 3

Source: PubMed Central Open Access, NCBI / U.S. National Library of Medicine

Frontiers in GeneticsLast synced 8/4/2026Status: syncedPMID: 42544324 pmidDOI: 10.3389/fgene.2026.1815601

Background Multiple mitochondrial dysfunction syndrome type 3 (MMDS3; OMIM #615330) is a rare autosomal recessive disorder caused by mutations in. Its complex clinical presentation and molecular pathogenesis remain incompletely understood. Methods The study included comprehensive clinical evaluation,7 genetic testing, Western Blotting for protein expression, and transcriptomic and metabolomic analyses of amniotic fluid cells. Results The proband presented with typical MMDS3 features, and both affected siblings carried compound heterozygousmissense mutations (c.310G>T and c.826C>T) leading to reduced IBA57 protein expression. RNA-seq revealed transcriptional dysregulation of the PI3K-Akt signaling pathway, and metabolomics demonstrated TCA cycle disturbances in amniocytes. Respiratory chain enzyme assays showed a selective deficiency of complex II activity in fetal liver. Conclusion The compound heterozygousmutations c.310G>T and c.826C>T lead to reduced IBA57 protein expression, selective impairment of respiratory chain complex II, and transcriptional dysregulation of the PI3K-Akt pathway, together contributing to the MMDS3 phenotype in the proband and the affected fetus.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.